Figure 1. Graphical description of ovarian cancer epidemiology (case incidence) in Belarus, 1995, 1999, 2004. Data taken from reference [34].
| Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc |
| Journal website http://www.jocmr.org |
Review
Volume 1, Number 5, December 2009, pages 249-261
Computer-aided Image Processing of Angiogenic Histological
Figure
Table
| Endothelial marker | Laboratory and clinical qualities |
|---|---|
| Text partially derived from [2, 38] | |
| CD31 | - commonly used |
| - cross-reacts with plasma cells | |
| - frequent antigen loss occurs due to fixatives containing acetic acid | |
| - infiltrates sometimes obscure microvessels, especially single cell sprouts | |
| CD34 | - the most reproducible endothelial cell highlighter |
| - highlight perivascular stromal cells | |
| CD105 | - proliferation-associated and hypoxia-inducible protein |
| - preferentially expressed in the activated endothelial cells participating in neoangiogenesis | |
| - undetectable or weakly expressed in vessels of normal tissues | |
| Tie-2/Tek | - endothelium-specific receptor tyrosine kinase |
| - identifies stromal vessels | |
| E-9 | - protein specific for activated/proliferating endothelial cells |